Our previous studies demonstrated that DC-based vaccines were safe and induced the expansion of circulating CD4+ T cells and CD8+ T cells that are specific for tumor antigens, which was synergistically enhanced by the combination of lenalidomide (21, 22, 36). The gene discussed is CD8A; the disease is neoplasm.